US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
570 companies in Healthcare · page 3 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Healthcare | $3.66Bpit | $75.1M | 160.6% | — | -15.1% | — | — |
| Autolus Therapeutics plc (AUTL) | Healthcare | $431.2Mpit | $75.4M | 644.9% | — | -161.4% | — | — |
| CytomX Therapeutics, Inc. (CTMX) | Healthcare | $523.0Mpit | $76.2M | -44.8% | -22.8% | -17.5% | — | — |
| Burning Rock Biotech Ltd (BNR) | Healthcare | $133.5Mvendor | $77.2M | 9.2% | -10.3% | -10.3% | — | — |
| Sight Sciences, Inc. (SGHT) | Healthcare | $495.2Mpit | $77.4M | -3.1% | -49.7% | -60.1% | — | — |
| Pro Dex Inc. (PDEX) | Healthcare | $199.8Mpit | $77.5M | 16.5% | 17.6% | 28.7% | 15.2 | — |
| Eton Pharmaceuticals, Inc. (ETON) | Healthcare | $1.43Bpit | $80.0M | 104.9% | -5.8% | -17.6% | — | — |
| TELA Bio, Inc. (TELA) | Healthcare | $43.3Mpit | $80.3M | 15.8% | -48.4% | -615.1% | — | — |
| ADC Therapeutics SA (ADCT) | Healthcare | $183.8Mpit | $81.4M | 14.9% | — | — | — | — |
| MeiraGTx Holdings plc (MGTX) | Healthcare | $938.3Mpit | $81.4M | 144.6% | — | — | — | — |
| Fitlife Brands, Inc. (FTLF) | Healthcare | $77.2Mpit | $81.5M | 26.4% | 7.8% | 14.5% | 43.7 | — |
| Arcturus Therapeutics Holdings Inc. (ARCT) | Healthcare | $296.2Mpit | $82.0M | -46.1% | -80.2% | -30.7% | — | — |
| Iradimed Corp. (IRMD) | Healthcare | $1.12Bpit | $83.8M | 14.4% | 26.8% | 23.8% | 49.0 | 1.4% |
| Nurix Therapeutics, Inc. (NRIX) | Healthcare | $2.79Bpit | $84.0M | 54.0% | — | -49.1% | — | — |
| ARS Pharmaceuticals, Inc. (SPRY) | Healthcare | $400.8Mpit | $84.3M | -5.5% | — | -149.9% | — | — |
| 4D Molecular Therapeutics, Inc. (FDMT) | Healthcare | $723.7Mvendor | $85.2M | 230194.6% | — | -27.7% | — | — |
| Delcath Systems, Inc. (DCTH) | Healthcare | $510.1Mpit | $85.2M | 129.1% | 3.2% | 2.4% | — | — |
| Standard Biotools Inc. (LAB) | Healthcare | $249.5Mpit | $85.3M | -6.2% | -87.8% | -17.7% | — | — |
| LakeShore Biopharma Co., Ltd. (LSBCF) | Healthcare | — | $85.7M | 6.0% | -16.3% | -20.0% | — | — |
| Harvard Bioscience Inc. (HBIO) | Healthcare | $38.0Mpit | $86.5M | -8.1% | -65.5% | -412.8% | — | — |
| Cytokinetics Inc. (CYTK) | Healthcare | $8.74Bpit | $88.0M | 376.6% | — | — | — | — |
| Biodesix Inc. (BDSX) | Healthcare | $252.5Mpit | $88.5M | 24.1% | -39.8% | — | — | — |
| Ceribell, Inc. (CBLL) | Healthcare | $1.04Bpit | $89.1M | 36.1% | -60.0% | -34.4% | — | — |
| VASO Corp (VASO) | Healthcare | $51.0Mpit | $89.1M | 2.7% | 1.8% | 5.3% | — | — |
| Pulmonx Corp (LUNG) | Healthcare | $80.7Mpit | $90.5M | 8.0% | -59.7% | -99.8% | — | — |
| Siga Technologies Inc. (SIGA) | Healthcare | $224.2Mpit | $94.6M | -31.8% | 24.6% | 11.7% | — | 19.4% |
| Kestra Medical Technologies, Ltd. (KMTS) | Healthcare | $1.71Bpit | $95.1M | 59.0% | — | -50.7% | — | — |
| Biolife Solutions Inc. (BLFS) | Healthcare | $1.89Bvendor | $96.2M | 28.9% | -4.8% | -1.2% | — | — |
| Butterfly Network, Inc. (BFLY) | Healthcare | $1.95Bpit | $97.6M | 19.0% | -79.0% | -39.3% | — | — |
| NeuroPace Inc (NPCE) | Healthcare | $451.0Mpit | $100.0M | 25.1% | -21.5% | -112.8% | — | — |
| Beta Bionics, Inc. (BBNX) | Healthcare | $827.8Mpit | $100.3M | 53.9% | -73.0% | -25.5% | — | — |
| Sutro Biopharma, Inc. (STRO) | Healthcare | $154.7Mpit | $102.5M | 65.2% | — | — | — | — |
| Sanara MedTech Inc. (SMTI) | Healthcare | $301.4Mpit | $103.1M | 19.0% | -36.4% | -633.5% | — | — |
| Owlet, Inc. (OWLT) | Healthcare | $121.3Mpit | $105.7M | 35.4% | -37.5% | — | — | — |
| Zymeworks Inc. (ZYME) | Healthcare | $2.00Bpit | $106.0M | 38.9% | -76.6% | -30.2% | — | — |
| Zevra Therapeutics, Inc. (ZVRA) | Healthcare | $582.6Mpit | $106.5M | 350.9% | 78.2% | 53.8% | 10.5 | — |
| Theravance Biopharma, Inc. (TBPH) | Healthcare | $884.2Mvendor | $107.5M | 66.9% | 98.5% | 35.7% | — | — |
| Mannatech Inc. (MTEX) | Healthcare | $16.5Mpit | $108.0M | -8.3% | -14.1% | — | — | — |
| Century Therapeutics, Inc. (IPSC) | Healthcare | $286.1Mpit | $109.2M | 1556.8% | -8.8% | -6.0% | — | — |
| UroGen Pharma Ltd. (URGN) | Healthcare | $1.69Bpit | $109.8M | 21.4% | — | — | — | — |
| Geospace Technologies Corp. (GEOS) | Healthcare | $54.7Mpit | $110.8M | -18.3% | -8.8% | -7.7% | — | — |
| Anika Therapeutics, Inc. (ANIK) | Healthcare | $286.7Mpit | $112.8M | -5.9% | -9.6% | -7.6% | — | — |
| ImmunityBio, Inc. (IBRX) | Healthcare | $8.81Bpit | $113.3M | 668.3% | — | — | — | — |
| Agenus Inc. (AGEN) | Healthcare | $278.2Mpit | $114.2M | 10.4% | -2.7% | — | — | — |
| Orasure Technologies Inc. (OSUR) | Healthcare | $253.8Mpit | $115.0M | -38.1% | -59.8% | -20.2% | — | — |
| Gyre Therapeutics, Inc. (GYRE) | Healthcare | $653.4Mpit | $116.6M | 10.2% | 8.5% | — | — | — |
| Outset Medical, Inc. (OM) | Healthcare | $78.4Mpit | $119.5M | 5.1% | -68.3% | -64.3% | — | — |
| Atara Biotherapeutics, Inc. (ATRA) | Healthcare | $93.9Mpit | $120.8M | -6.3% | 27.1% | — | — | — |
| Monte Rosa Therapeutics, Inc. (GLUE) | Healthcare | $947.8Mpit | $123.7M | 63.5% | -31.2% | -16.6% | — | 0.0% |
| Xencor Inc (XNCR) | Healthcare | $1.87Bpit | $125.6M | 13.7% | -73.2% | -14.5% | — | — |
| Lifecore Biomedical, Inc. \de\ (LFCR) | Healthcare | $241.1Mpit | $128.9M | 0.5% | -30.0% | — | — | — |
| Niagen Bioscience, Inc. (NAGE) | Healthcare | $199.4Mpit | $129.4M | 29.9% | 13.4% | 22.7% | 14.1 | — |
| Xtant Medical Holdings, Inc. (XTNT) | Healthcare | $39.6Mpit | $133.9M | 14.2% | 3.7% | 9.8% | — | — |
| RxSight, Inc. (RXST) | Healthcare | $208.8Mpit | $134.5M | -3.9% | -29.0% | -14.1% | — | — |
| Nrc Health (NRC) | Healthcare | $472.9Mpit | $137.4M | -4.0% | 8.4% | 82.9% | — | 2.7% |
| Quanterix Corp (QTRX) | Healthcare | $135.3Mpit | $138.9M | 1.1% | -77.1% | -36.2% | — | — |
| Beam Therapeutics Inc. (BEAM) | Healthcare | $2.48Bpit | $139.7M | 120.0% | -57.2% | -6.5% | — | — |
| Natural Alternatives International Inc. (NAII) | Healthcare | $7.5Mvendor | $142.5M | 9.7% | -14.5% | -41.4% | — | — |
| InfuSystem Holdings, Inc (INFU) | Healthcare | $281.6Mpit | $143.4M | 6.4% | 4.6% | 11.6% | 34.7 | — |
| Karyopharm Therapeutics Inc. (KPTI) | Healthcare | $12.4Mpit | $146.1M | 0.6% | — | — | — | — |
| Cronos Group Inc. (CRON) | Healthcare | $1.25Bpit | $146.6M | 24.6% | -6.4% | -0.8% | — | — |
| GRAIL, Inc. (GRAL) | Healthcare | $5.68Bpit | $147.2M | 17.2% | — | -15.8% | — | — |
| Elite Pharmaceuticals Inc. (ELTP) | Healthcare | $269.3Mpit | $148.9M | 77.1% | 30.1% | 45.4% | — | — |
| Neuronetics, Inc. (STIM) | Healthcare | $160.8Mpit | $149.2M | 99.2% | -26.1% | -148.6% | — | — |
| Macrogenics Inc. (MGNX) | Healthcare | $231.2Mpit | $149.5M | -0.3% | -49.9% | -134.2% | — | — |
| Airsculpt Technologies, Inc. (AIRS) | Healthcare | $86.5Mpit | $151.8M | -15.8% | -7.7% | -13.3% | — | — |
| Heron Therapeutics, Inc. (HRTX) | Healthcare | $56.2Mpit | $154.9M | 7.4% | -13.0% | -140.9% | — | — |
| Liquidia Corp (LQDA) | Healthcare | $3.55Bpit | $158.3M | 1031.2% | -43.5% | -154.0% | — | — |
| Marimed Inc. (MRMD) | Healthcare | $22.2Mpit | $159.8M | 1.3% | -9.1% | — | — | — |
| Pacific Biosciences of California, Inc. (PACB) | Healthcare | $640.3Mpit | $160.0M | 3.9% | — | -10214.5% | — | — |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Healthcare | $664.0Mpit | $170.2M | -25.1% | — | -61.5% | — | — |
| REGENXBIO Inc. (RGNX) | Healthcare | $441.0Mpit | $170.4M | 104.5% | — | -188.7% | — | — |
| Syndax Pharmaceuticals Inc (SNDX) | Healthcare | $1.20Bpit | $172.4M | 627.8% | — | -441.6% | — | — |
| SBC Medical Group Holdings Inc (SBC) | Healthcare | $543.0Mpit | $173.6M | -15.5% | 29.4% | 19.4% | 11.3 | — |
| Phathom Pharmaceuticals, Inc. (PHAT) | Healthcare | $567.1Mpit | $175.1M | 216.9% | — | — | — | — |
| Heartflow, Inc. (HTFL) | Healthcare | $4.82Bpit | $176.0M | 39.9% | -66.3% | -38.8% | — | — |
| Cryoport, Inc. (CYRX) | Healthcare | $938.5Mpit | $176.2M | 12.4% | 44.4% | 15.6% | — | — |
| Adaptimmune Therapeutics PLC (ADAPY) | Healthcare | $8.0Mvendor | $178.0M | 195.3% | -39.8% | -597.6% | — | — |
| Glass House Brands Inc. (GLAS) | Healthcare | $214.9Mvendor | $182.0M | -9.4% | -16.3% | — | — | — |
| Lifevantage Corp (LFVN) | Healthcare | $74.9Mpit | $182.6M | -20.1% | 2.8% | 15.1% | 14.9 | 3.1% |
| Stoke Therapeutics, Inc. (STOK) | Healthcare | $1.62Bpit | $184.4M | 404.5% | -3.7% | -2.0% | — | — |
| Maravai Lifesciences Holdings, Inc. (MRVI) | Healthcare | $2.67Bvendor | $185.7M | -28.3% | -70.4% | -35.1% | — | — |
| Rhythm Pharmaceuticals, Inc. (RYTM) | Healthcare | $6.15Bpit | $189.8M | 45.8% | — | — | — | — |
| biote Corp. (BTMD) | Healthcare | $36.3Mvendor | $192.2M | -2.5% | 14.1% | — | — | — |
| Lakeland Industries Inc. (LAKE) | Healthcare | $91.7Mpit | $192.6M | 15.2% | -13.1% | -19.6% | — | — |
| LifeMD, Inc. (LFMD) | Healthcare | $104.6Mpit | $194.1M | 25.3% | 7.4% | 62.0% | — | — |
| Strata Critical Medical, Inc. (SRTA) | Healthcare | $412.3Mpit | $197.1M | 34.3% | 21.0% | 14.8% | 9.2 | — |
| SI-BONE, Inc. (SIBN) | Healthcare | $962.7Mpit | $200.9M | 20.2% | -9.4% | -10.6% | — | — |
| Cytek Biosciences, Inc. (CTKB) | Healthcare | $714.9Mpit | $201.5M | 0.5% | -33.0% | -19.5% | — | — |
| Establishment Labs Holdings Inc. (ESTA) | Healthcare | $1.89Bpit | $211.1M | 27.1% | -24.2% | -216.9% | — | — |
| Treace Medical Concepts, Inc. (TMCI) | Healthcare | $277.7Mpit | $212.7M | 1.6% | -27.7% | -67.6% | — | — |
| Amarin Corp. Plc\uk (AMRN) | Healthcare | $243.1Mvendor | $213.6M | -6.5% | -18.2% | -8.4% | — | — |
| Vanda Pharmaceuticals Inc. (VNDA) | Healthcare | $242.5Mpit | $216.1M | 8.7% | — | -67.4% | — | — |
| IDEAYA Biosciences, Inc. (IDYA) | Healthcare | $3.49Bpit | $218.7M | 3024.4% | -52.0% | -11.1% | — | — |
| Axogen, Inc. (AXGN) | Healthcare | $1.96Bpit | $225.2M | 20.2% | -7.0% | -12.2% | — | — |
| Puma Biotechnology, Inc. (PBYI) | Healthcare | $562.7Mpit | $228.4M | -0.9% | 13.6% | 23.9% | 20.9 | — |
| Talkspace, Inc. (TALK) | Healthcare | $870.6Mvendor | $228.9M | 22.0% | 3.4% | 6.7% | — | — |
| Cerus Corp. (CERS) | Healthcare | $439.3Mpit | $233.8M | 16.1% | -6.7% | -24.1% | — | — |
| Anaptysbio, Inc. (ANAB) | Healthcare | $1.44Bpit | $234.6M | 157.0% | -5.6% | -35.6% | — | — |
| Akebia Therapeutics, Inc. (AKBA) | Healthcare | $155.8Mpit | $236.2M | 47.5% | -2.3% | -16.4% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.